< Back to previous page

Publication

159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Journal Contribution - Journal Article

Journal: Annals Oncol 2002

ISSN: 0923-7534

Issue: suppl 7

Volume: 32

Pages: 1449-1450

Publication year:2021

DOI: https://doi.org/10.1016/j.annonc.2021.10.178
WoS Id: 000731051400162

Accessibility:Open

See also: Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma